GL1X · GenesisL1 explorer

MolNFT v2 · #129909 · protein

Crystal structure of Alpha1-antichymotrypsin variant DBS-II: a drug-binding serpin for doxorubicin

5OM7: “Crystal structure of Alpha1-antichymotrypsin variant DBS-II: a drug-binding serpin for doxorubicin”. X-ray diffraction at 1.727, 1 ligand (DM2). MolNFT v2 #129909 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5OM7
Type
protein
Length
371 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.727
Source
Homo sapiens
UniProt
P01011
Ligands
DM2

Structure

x-ray diffraction · resolution 1.727 · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein338—P01011
B—protein33—P01011

Ligands and binding sites

  • DM2 · Doxorubicin · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5OM7 · Crystal structure of ALPHA1-antichymotrypsin variant dbs-II: a drug- binding serpin for… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01011 · AlphaFold monomer V2.0 prediction for alpha-1-antichymotrypsin (P01011) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.